Thermo Fisher Scientific (TMO) Now Covered by Analysts at Evercore ISI
Stock analysts at Evercore ISI started coverage on shares of Thermo Fisher Scientific (NYSE:TMO) in a research report issued on Wednesday, January 3rd. The firm set an “outperform” rating and a $220.00 price target on the medical research company’s stock. Evercore ISI’s target price points to a potential upside of 0.54% from the stock’s current price.
TMO has been the subject of a number of other research reports. Jefferies Group reiterated a “hold” rating and issued a $195.00 price objective on shares of Thermo Fisher Scientific in a report on Thursday, September 28th. Zacks Investment Research upgraded Thermo Fisher Scientific from a “hold” rating to a “buy” rating and set a $208.00 price target for the company in a report on Thursday, September 7th. Leerink Swann restated an “outperform” rating and set a $200.00 price target (down from $216.00) on shares of Thermo Fisher Scientific in a report on Monday, December 4th. Morgan Stanley restated an “overweight” rating and set a $220.00 price target on shares of Thermo Fisher Scientific in a report on Wednesday, September 6th. Finally, Goldman Sachs Group began coverage on Thermo Fisher Scientific in a report on Tuesday, September 26th. They set a “buy” rating and a $225.00 price target for the company. Two research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the company’s stock. Thermo Fisher Scientific has a consensus rating of “Buy” and an average price target of $212.21.
Thermo Fisher Scientific (TMO) opened at $218.81 on Wednesday. The company has a quick ratio of 0.81, a current ratio of 1.26 and a debt-to-equity ratio of 0.85. The stock has a market capitalization of $87,280.00, a price-to-earnings ratio of 37.15, a price-to-earnings-growth ratio of 1.78 and a beta of 1.06. Thermo Fisher Scientific has a twelve month low of $142.66 and a twelve month high of $220.10.
Institutional investors have recently added to or reduced their stakes in the stock. Bank of Nova Scotia Trust Co. purchased a new stake in shares of Thermo Fisher Scientific during the third quarter valued at $106,000. Chicago Partners Investment Group LLC purchased a new stake in shares of Thermo Fisher Scientific during the second quarter valued at $108,000. Shine Investment Advisory Services Inc. purchased a new stake in shares of Thermo Fisher Scientific during the second quarter valued at $113,000. Ropes Wealth Advisors LLC boosted its position in shares of Thermo Fisher Scientific by 15.8% during the second quarter. Ropes Wealth Advisors LLC now owns 710 shares of the medical research company’s stock valued at $124,000 after buying an additional 97 shares during the last quarter. Finally, Atlantic Trust LLC purchased a new position in Thermo Fisher Scientific in the second quarter worth about $138,000. 86.39% of the stock is currently owned by institutional investors.
Thermo Fisher Scientific Company Profile
Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.
Receive News & Ratings for Thermo Fisher Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific and related companies with MarketBeat.com's FREE daily email newsletter.